MedPath

The prospective study of effect of ifenprodil on relapse prevention in patients with substance dependence

Not Applicable
Conditions
Alcohol dependence
Registration Number
JPRN-UMIN000006347
Lead Sponsor
Tokyo Metropolitan Institute of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with noncompliance 2) Participants of other clinical trials 3) Patients with comorbid psychiatric disorder (e.g. schizophrenia) or serious physical diseases 4) Patients with considerably low motivation for treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Slip: alcohol use during the past month 2) Level of alcohol drinking: frequency and amount of alcohol drinking 3) Dropout: dropout of treatment 4) Craving and relapse risk: assessment by self-rating questionnaire including VAS and Alcohol Relapse Risk Scale (ARRS)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath